JP2018526403A5 - - Google Patents

Download PDF

Info

Publication number
JP2018526403A5
JP2018526403A5 JP2018512407A JP2018512407A JP2018526403A5 JP 2018526403 A5 JP2018526403 A5 JP 2018526403A5 JP 2018512407 A JP2018512407 A JP 2018512407A JP 2018512407 A JP2018512407 A JP 2018512407A JP 2018526403 A5 JP2018526403 A5 JP 2018526403A5
Authority
JP
Japan
Prior art keywords
formulation
antibody
intestinal wall
item
penetrating member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2018512407A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018526403A (ja
Filing date
Publication date
Priority claimed from US15/150,379 external-priority patent/US11548940B2/en
Application filed filed Critical
Priority claimed from PCT/US2016/050832 external-priority patent/WO2017044665A1/en
Publication of JP2018526403A publication Critical patent/JP2018526403A/ja
Publication of JP2018526403A5 publication Critical patent/JP2018526403A5/ja
Priority to JP2021125408A priority Critical patent/JP2021169530A/ja
Withdrawn legal-status Critical Current

Links

JP2018512407A 2015-09-08 2016-09-08 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤 Withdrawn JP2018526403A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021125408A JP2021169530A (ja) 2015-09-08 2021-07-30 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562215586P 2015-09-08 2015-09-08
US62/215,586 2015-09-08
US15/150,379 US11548940B2 (en) 2014-05-15 2016-05-09 Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
US15/150,379 2016-05-09
PCT/US2016/050832 WO2017044665A1 (en) 2015-09-08 2016-09-08 Pcsk9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021125408A Division JP2021169530A (ja) 2015-09-08 2021-07-30 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤

Publications (2)

Publication Number Publication Date
JP2018526403A JP2018526403A (ja) 2018-09-13
JP2018526403A5 true JP2018526403A5 (enExample) 2019-10-03

Family

ID=58240088

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2018512407A Withdrawn JP2018526403A (ja) 2015-09-08 2016-09-08 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤
JP2021125408A Pending JP2021169530A (ja) 2015-09-08 2021-07-30 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤
JP2023084891A Pending JP2023104992A (ja) 2015-09-08 2023-05-23 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2021125408A Pending JP2021169530A (ja) 2015-09-08 2021-07-30 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤
JP2023084891A Pending JP2023104992A (ja) 2015-09-08 2023-05-23 嚥下可能な薬物送達デバイスを使用する腸管の管腔中への送達のためのｐｃｓｋ９抗体製剤

Country Status (7)

Country Link
EP (1) EP3347050B1 (enExample)
JP (3) JP2018526403A (enExample)
CN (1) CN108401419A (enExample)
AU (2) AU2016320867B2 (enExample)
CA (1) CA2997958A1 (enExample)
DK (1) DK3347050T3 (enExample)
WO (1) WO2017044665A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10689460B2 (en) 2014-05-15 2020-06-23 Incube Labs, Llc PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device
CA2949236C (en) 2014-05-15 2023-06-13 Incube Labs, Llc Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins
US11541015B2 (en) 2017-05-17 2023-01-03 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
CA3063711A1 (en) 2017-05-17 2018-11-22 Massachusetts Institute Of Technology Self-righting systems, methods, and related components
EP3793667A1 (en) 2018-05-17 2021-03-24 Massachusetts Institute of Technology Systems for electrical stimulation
US12128133B2 (en) 2018-09-25 2024-10-29 Rani Therapeutics, Llc Ingestible device with expandable enclosure
EP3905999A4 (en) * 2018-12-31 2022-09-28 Rani Therapeutics, LLC THERAPEUTIC PREPARATIONS FOR DELIVERY INTO A LUMEN OF THE INTESTINAL TRACT VIA INGESTIONABLE DELIVERY DEVICE
WO2020160399A1 (en) 2019-02-01 2020-08-06 Massachusetts Institute Of Technology Systems and methods for liquid injection
KR20220004148A (ko) * 2019-05-03 2022-01-11 라니 테라퓨틱스, 엘엘씨 삼킬 수 있는 약물 전달 장치를 사용하여 장관 조직으로 전달하기 위한 응고인자 제제
US11541216B2 (en) 2019-11-21 2023-01-03 Massachusetts Institute Of Technology Methods for manufacturing tissue interfacing components

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8562589B2 (en) 2009-12-24 2013-10-22 Rani Therapeutics, Llc Swallowable drug delivery device and method of delivery
CN105999526B (zh) * 2009-12-24 2019-07-05 拉尼医疗有限公司 可吞咽式药剂递送装置和药剂递送方法
US9149617B2 (en) * 2010-12-23 2015-10-06 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
JP6029664B2 (ja) * 2011-06-29 2016-11-24 ラニ セラピューティクス， エルエルシー 嚥下可能な薬物送達デバイスを用いる腸管の内腔へ送達するための治療剤製剤
AU2012275417B9 (en) * 2011-06-29 2017-08-31 Rani Therapeutics, Llc Device, system and methods for the oral delivery of therapeutic compounds
BR112014000392A2 (pt) * 2011-07-14 2017-02-21 Pfizer tratamento com anticorpos anti-pcsk9
EP3104879A2 (en) 2014-02-14 2016-12-21 Regeneron Pharmaceuticals, Inc. Methods for treating patients with hypercholesterolemia that is not adequately controlled by moderate-dose statin therapy
AU2016261599B2 (en) * 2015-05-08 2021-08-26 Rani Therapeutics, Llc Anti-interleukin antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device

Similar Documents

Publication Publication Date Title
AU2020256337B2 (en) Dosing regimens for echinocandin class compounds
JP5749255B2 (ja) Ｌ−オルニチンフェニル酢酸塩を用いる門脈圧亢進の治療及び肝機能の修復
JP4489356B2 (ja) 浸透促進剤
EP3316873B1 (en) Device for oral delivery of active agents
JP2005506367A5 (enExample)
JP2018519313A5 (enExample)
Singh et al. Pulsatile drug delivery system: an approach of medication according to circadian rhythm
CA2654566A1 (en) Solid oral dosage form containing an enhancer
US20150024031A1 (en) Methods And Compositions For Reducing Pain, Inflammation, And/Or Immunological Reactions Associated With Parenterally Administering A Primary Therapeutic Agent
CN101277684A (zh) 至少一种活性成分改善释放的微粒及含有该微粒的口服药物剂型
US20110218246A1 (en) Methods of treating non-nociceptive pain states with gastric retentive gabapentin
JP2022524446A5 (enExample)
JP2023120445A (ja) テルリプレシン組成物およびその使用方法
JP2005528430A5 (enExample)
Gupta et al. Old Drugs, New Delivery Systems in Parkinson's Disease.
WO2021145436A1 (ja) 目的とする既知の薬剤又はその等価物質の新たな適応症の予測方法、予測装置、及び予測プログラム
JP2018520995A5 (enExample)
NZ787785A (en) Delayed release deferiprone tablets and methods of using the same
CN104379138B (zh) 阿坎酸制剂、其使用方法及包含阿坎酸制剂的组合
CN117545509A (zh) 寡核苷酸的口服递送
WO2014176417A1 (en) Topical preparation for bypassing gi tract, delivery of therapeutics, and trans-epithelial drug delivery system
JP2019517490A (ja) がん療法のためのメトロノミック経口ゲムシタビン
JP4370054B2 (ja) 腸粘膜傷害の予防及び治療剤
Pandey et al. Innovative approaches in HELICOBACTER pylori therapy: Clinical trials and advancements in Gastro-Retentive drug delivery systems
RU2401112C2 (ru) Фармацевтическая композиция для лечения аутоиммунных заболеваний, связанных с повышенным образованием антител к нуклеиновым кислотам